Therefore, we try to explore the correlation between NFE2L3 and Wnt/β-catenin signaling pathway in HCC, we found that silencing of NFE2L3 decreased the expression of β-catenin and the target genes TCF4 and cyclin D1. The gene discussed is CCND1; the disease is hepatocellular carcinoma.